- Home
- CHEK vs EVOK Comparison
CHEK vs EVOK Comparison
Compare CHEK & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- EVOK
- Stock Information
- Founded
- CHEK 2004
- EVOK 2007
- Country
- CHEK Israel
- EVOK United States
- Employees
- CHEK 85
- EVOK N/A
- Industry
- CHEK Medical Electronics
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- CHEK Health Care
- EVOK Health Care
- Exchange
- CHEK Nasdaq
- EVOK Nasdaq
- Market Cap
- CHEK 4.8M
- EVOK 4.2M
- IPO Year
- CHEK 2015
- EVOK 2013
- Fundamental
- Price
- CHEK $0.80
- EVOK $2.95
- Analyst Decision
- CHEK
- EVOK
- Analyst Count
- CHEK 0
- EVOK 0
- Target Price
- CHEK N/A
- EVOK N/A
- AVG Volume (30 Days)
- CHEK 125.3K
- EVOK 14.3K
- Earning Date
- CHEK 06-17-2025
- EVOK 05-13-2025
- Dividend Yield
- CHEK N/A
- EVOK N/A
- EPS Growth
- CHEK N/A
- EVOK N/A
- EPS
- CHEK N/A
- EVOK N/A
- Revenue
- CHEK N/A
- EVOK $11,594,083.00
- Revenue This Year
- CHEK N/A
- EVOK $57.82
- Revenue Next Year
- CHEK N/A
- EVOK $59.12
- P/E Ratio
- CHEK N/A
- EVOK N/A
- Revenue Growth
- CHEK N/A
- EVOK 89.89
- 52 Week Low
- CHEK $0.56
- EVOK $1.94
- 52 Week High
- CHEK $3.04
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- CHEK 46.52
- EVOK 38.86
- Support Level
- CHEK $0.78
- EVOK $3.33
- Resistance Level
- CHEK $0.86
- EVOK $3.66
- Average True Range (ATR)
- CHEK 0.04
- EVOK 0.29
- MACD
- CHEK -0.01
- EVOK -0.06
- Stochastic Oscillator
- CHEK 15.73
- EVOK 2.99
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.